{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06488742",
            "orgStudyIdInfo": {
                "id": "KO-104"
            },
            "organization": {
                "fullName": "Nexgen Dermatologics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "The Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in Patients With Atopic Dermatitis",
            "officialTitle": "Efficacy of 3% Kanuka Oil Versus 1% Hydrocortisone Cream in the Treatment of Patients With Mild Atopic Dermatitis",
            "therapeuticArea": [
                "Dermatology",
                "Other"
            ],
            "study": "the-efficacy-of-kanuka-oil-versus-hydrocortisone-cream-in-patients-with-atopic-dermatitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-06",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-11-01",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-10",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-20",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-06-28",
            "studyFirstSubmitQcDate": "2024-06-28",
            "studyFirstPostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-06-28",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nexgen Dermatologics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "Atopic dermatitis is a common disease affecting millions worldwide. A common associated symptom in this population is pruritus. We seek to investigate the use of an natural, over-the-counter cosmeceutical to help this population",
            "detailedDescription": "There are many treatment options available for atopic dermatitis yet many patients still suffer from the underlying symptomatology. It is important to explore other treatment alternatives to help this population."
        },
        "conditionsModule": {
            "conditions": [
                "Dermatitis, Atopic",
                "Pruritus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 60,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "3% Kanuka Oil Cream",
                    "type": "EXPERIMENTAL",
                    "description": "3% kanuka oil cream will be applied topically to the affected area twice a day for 28 days",
                    "interventionNames": [
                        "Other: 3% kanuka oil"
                    ]
                },
                {
                    "label": "1% Hydrocortisone Cream",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "1% Hydrocortisone Cream will be applied topically to the affected area twice a day for 28 days",
                    "interventionNames": [
                        "Other: 3% kanuka oil"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "3% kanuka oil",
                    "description": "To assess the efficacy in patients with mild atopic dermatitis, 3% kanuka oil will be applied twice a day for 28 days. 3% kanuka oil is a naturally occurring extract from the kanuka tree and is considered an over-the-counter agent.",
                    "armGroupLabels": [
                        "1% Hydrocortisone Cream",
                        "3% Kanuka Oil Cream"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "ISGA",
                    "description": "Investigator scale to determine imporvement in condition",
                    "timeFrame": "28 days"
                },
                {
                    "measure": "WI-NRS",
                    "description": "Scale generated by patient's responses to survey questions to assess improvement in itch",
                    "timeFrame": "28 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* age greater than 12 years, diagnosis of atopic dermatitis for longer than 2 years, investigator's static global assessment score of either 2 or 3, and initial worst itch numerical rating scale (WI-NRS) for itch greater than 4.\n\nExclusion Criteria:\n\n* the use of topical or systemic corticosteroids within 28 days of entering the study, the use of any other non-emollient therapy within 28 days of entering the study,nursing, and pregnancy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "12 Years",
            "maximumAge": "75 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Joshua Berlin, MD",
                    "role": "CONTACT",
                    "phone": "561-729-5252",
                    "email": "joshberlin@hotmail.com"
                }
            ],
            "locations": [
                {
                    "facility": "Berlin Center",
                    "status": "RECRUITING",
                    "city": "Boynton Beach",
                    "state": "Florida",
                    "zip": "33437",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "H G Berlin, ESQ",
                            "role": "CONTACT",
                            "phone": "561-739-5252",
                            "email": "garyberlin17@hotmail.com"
                        },
                        {
                            "name": "Joshua M Berlin, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.52535,
                        "lon": -80.06643
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35865740",
                    "type": "BACKGROUND",
                    "citation": "Shortt N, Martin A, Kerse K, Shortt G, Vakalalabure I, Barker L, Singer J, Black B, Liu A, Eathorne A, Weatherall M, Rademaker M, Armour M, Beasley R, Semprini A; Medical Research Institute of New Zealand's Pharmacy Research Network. Efficacy of a 3% Kanuka oil cream for the treatment of moderate-to-severe eczema: A single blind randomised vehicle-controlled trial. EClinicalMedicine. 2022 Jul 15;51:101561. doi: 10.1016/j.eclinm.2022.101561. eCollection 2022 Sep."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO",
            "description": "The individual participant data will be confidential and not shared unless authorized by the participant"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003876",
                    "term": "Dermatitis, Atopic"
                },
                {
                    "id": "D000003872",
                    "term": "Dermatitis"
                },
                {
                    "id": "D000011537",
                    "term": "Pruritus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                },
                {
                    "id": "D000012873",
                    "term": "Skin Diseases, Genetic"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000017443",
                    "term": "Skin Diseases, Eczematous"
                },
                {
                    "id": "D000006969",
                    "term": "Hypersensitivity, Immediate"
                },
                {
                    "id": "D000006967",
                    "term": "Hypersensitivity"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000012877",
                    "term": "Skin Manifestations"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7071",
                    "name": "Dermatitis, Atopic",
                    "asFound": "Dermatitis, Atopic",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7067",
                    "name": "Dermatitis",
                    "asFound": "Dermatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7655",
                    "name": "Eczema",
                    "relevance": "LOW"
                },
                {
                    "id": "M14396",
                    "name": "Pruritus",
                    "asFound": "Pruritus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15676",
                    "name": "Skin Diseases, Genetic",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M19712",
                    "name": "Skin Diseases, Eczematous",
                    "relevance": "LOW"
                },
                {
                    "id": "M10018",
                    "name": "Hypersensitivity",
                    "relevance": "LOW"
                },
                {
                    "id": "M10020",
                    "name": "Hypersensitivity, Immediate",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15680",
                    "name": "Skin Manifestations",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M9912",
                    "name": "Hydrocortisone",
                    "relevance": "LOW"
                },
                {
                    "id": "M155245",
                    "name": "Hydrocortisone 17-butyrate 21-propionate",
                    "relevance": "LOW"
                },
                {
                    "id": "M228609",
                    "name": "Hydrocortisone acetate",
                    "relevance": "LOW"
                },
                {
                    "id": "M263259",
                    "name": "Hydrocortisone hemisuccinate",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}